{"id":"https://openalex.org/W7217098259","doi":null,"title":"Effect of Antidiabetic Medications on Cancer Risk: Mechanisms and Clinical Evidence","display_name":"Effect of Antidiabetic Medications on Cancer Risk: Mechanisms and Clinical Evidence","alternate_titles":[],"publication_year":2026,"publication_date":"2026-04-28","ids":{"openalex":"https://openalex.org/W7217098259"},"language":"en","primary_location":{"id":"pmh:oai:ojs2.jchr.org:article/13525","doi":null,"is_oa":true,"landing_page_url":"https://jchr.org/index.php/JCHR/article/view/13525","pdf_url":"https://jchr.org/index.php/JCHR/article/download/13525/7310","source":{"id":"https://openalex.org/S2764499610","display_name":"Journal of chemical health risks","issn_l":"2251-6719","issn":["2251-6719","2251-6727"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319124","host_organization_name":"Azad University Cross Team","host_organization_lineage":["https://openalex.org/P4310319124"],"host_organization_lineage_names":["Azad University Cross Team"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2251-6719","raw_type":"info:eu-repo/semantics/article"},"parent_works":[],"lineage":["https://openalex.org/W7217098259"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://jchr.org/index.php/JCHR/article/download/13525/7310","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5154521228","display_name":"Satish Chandra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259076","display_name":"Vivek University","ror":"https://ror.org/01pwyb445","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405259076"]}],"countries":["IN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Satish Chandra","raw_affiliation_strings":["Department of Zoology , School of Sciences , Vivek University , Bijnor - 246701 , Uttar Pradesh , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Zoology , School of Sciences , Vivek University , Bijnor - 246701 , Uttar Pradesh , India","institution_ids":["https://openalex.org/I4405259076"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5154521228"],"corresponding_institution_ids":["https://openalex.org/I4405259076"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ampk","display_name":"AMPK","score":0.8899999856948853},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.972000002861023},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9559999704360962},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9789999723434448},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8230000138282776},{"id":"https://openalex.org/keywords/diabetes-and-cancer","display_name":"diabetes and cancer","score":0.49900001287460327},{"id":"https://openalex.org/keywords/oncogenic-signalling-pathways","display_name":"oncogenic signalling pathways","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7742000222206116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6877999901771545},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6348000168800354},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6155999898910522},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5964999794960022},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5203999876976013},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.4607999920845032},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45249998569488525},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.42329999804496765},{"id":"https://openalex.org/C3018449070","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signalling pathways","level":3,"score":0.4027999937534332},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3889000117778778},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3774000108242035},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.36469998955726624},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3488999903202057},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.3230000138282776},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.31040000915527344},{"id":"https://openalex.org/C2992704333","wikidata":"https://www.wikidata.org/wiki/Q5382717","display_name":"Cancer incidence","level":3,"score":0.30399999022483826},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.2948000133037567},{"id":"https://openalex.org/C39743133","wikidata":"https://www.wikidata.org/wiki/Q3262595","display_name":"Signalling","level":2,"score":0.2944999933242798},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.2944999933242798},{"id":"https://openalex.org/C112446052","wikidata":"https://www.wikidata.org/wiki/Q422579","display_name":"Insulin receptor","level":4,"score":0.29319998621940613},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.29089999198913574},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2870999872684479},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2838999927043915},{"id":"https://openalex.org/C2780234812","wikidata":"https://www.wikidata.org/wiki/Q1787013","display_name":"Cancer prevention","level":3,"score":0.2775999903678894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27630001306533813},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2703000009059906},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.2637999951839447},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.251800000667572}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:ojs2.jchr.org:article/13525","doi":null,"is_oa":true,"landing_page_url":"https://jchr.org/index.php/JCHR/article/view/13525","pdf_url":"https://jchr.org/index.php/JCHR/article/download/13525/7310","source":{"id":"https://openalex.org/S2764499610","display_name":"Journal of chemical health risks","issn_l":"2251-6719","issn":["2251-6719","2251-6727"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319124","host_organization_name":"Azad University Cross Team","host_organization_lineage":["https://openalex.org/P4310319124"],"host_organization_lineage_names":["Azad University Cross Team"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2251-6719","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:ojs2.jchr.org:article/13525","doi":null,"is_oa":true,"landing_page_url":"https://jchr.org/index.php/JCHR/article/view/13525","pdf_url":"https://jchr.org/index.php/JCHR/article/download/13525/7310","source":{"id":"https://openalex.org/S2764499610","display_name":"Journal of chemical health risks","issn_l":"2251-6719","issn":["2251-6719","2251-6727"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319124","host_organization_name":"Azad University Cross Team","host_organization_lineage":["https://openalex.org/P4310319124"],"host_organization_lineage_names":["Azad University Cross Team"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2251-6719","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7217098259.pdf","grobid_xml":"https://content.openalex.org/works/W7217098259.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1978281808","https://openalex.org/W1990586051","https://openalex.org/W2026967508","https://openalex.org/W2040608814","https://openalex.org/W2081540191","https://openalex.org/W2104195235","https://openalex.org/W2109600717","https://openalex.org/W2140164776","https://openalex.org/W2143756124","https://openalex.org/W2156370651","https://openalex.org/W2170585132","https://openalex.org/W2889646458","https://openalex.org/W2972869264","https://openalex.org/W4311263986"],"related_works":["https://openalex.org/W2097065650","https://openalex.org/W1768177901","https://openalex.org/W1983832091","https://openalex.org/W3094168521","https://openalex.org/W16275066","https://openalex.org/W4310208860","https://openalex.org/W2329089373","https://openalex.org/W3032236125","https://openalex.org/W4392597796","https://openalex.org/W2990724374"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,260],"increasing":[2],"body":[3,173],"of":[4,26,54,57,75,99,119,134,232,262,285],"evidence":[5],"suggests":[6],"that":[7],"antidiabetic":[8,58,76,286],"drugs":[9,59,192,287],"have":[10,84],"a":[11,85,205],"highly":[12,253],"complex":[13],"and":[14,31,39,47,63,103,117,138,155,174,177,188,199,235,256,280,283],"context-specific":[15],"interrelation":[16],"with":[17,288],"cancer":[18,61,79,115,162,263],"risk,":[19],"which":[20,184],"is":[21,107],"affected":[22],"through":[23],"the":[24,43,52,68,95,108,120,172,225,230,233,240,247,250],"interplay":[25],"metabolic":[27],"dysregulation,":[28],"pharmacological":[29],"processes,":[30],"oncogenic":[32],"signalling":[33,137],"pathways.":[34],"Objectives:":[35],"This":[36],"epidemiological,":[37,45],"clinical,":[38,46],"mechanistic":[40,48,211],"review":[41],"combines":[42],"available":[44],"data":[49,212],"to":[50,71,114,125],"investigate":[51],"effect":[53,74],"various":[55],"classes":[56],"on":[60,78,94],"development":[62],"progression.":[64],"Methods:":[65],"We":[66],"reviewed":[67],"recent":[69],"literature":[70],"find":[72],"out":[73],"medications":[77],"risk.":[80],"Results:":[81],"Antidiabetic":[82],"therapies":[83],"heterogeneous":[86],"impact,":[87],"i.e.":[88],"either":[89],"protective":[90,150],"or":[91],"promotive":[92],"based":[93],"drug":[96],"class,":[97],"length":[98],"exposure,":[100],"biological":[101,146],"context":[102],"patient-specific":[104],"characteristics.":[105],"Metformin":[106],"most":[109],"consistently":[110],"inverse":[111],"related":[112],"agent":[113],"incidence":[116],"mortality":[118],"existing":[121],"agents.":[122],"Its":[123],"ability":[124],"induce":[126],"AMP-activated":[127],"protein":[128],"kinase":[129],"(AMPK),":[130],"suppress":[131],"mammalian":[132],"target":[133],"rapamycin":[135],"(mTOR)":[136],"mitigate":[139],"hyperinsulinemia-induced":[140],"mitogenic":[141],"pathways":[142],"gives":[143],"it":[144],"great":[145],"plausibility":[147],"for":[148,249,252],"these":[149],"actions.":[151],"Conversely,":[152],"insulin":[153,156,169,176],"therapy":[154,198],"secretagogues,":[157],"including":[158],"sulfonylureas,":[159],"could":[160,269],"elevate":[161],"risk":[163,264],"in":[164,171,204,222,224,239,266,272,274],"some":[165],"circumstances":[166],"by":[167,229],"raising":[168],"levels":[170],"stimulating":[175],"insulin-like":[178],"growth":[179],"factor-1":[180],"(IGF-1)":[181],"receptor":[182],"signalling,":[183],"promotes":[185],"cell":[186],"proliferation":[187],"suppresses":[189],"apoptosis.":[190],"Other":[191],"such":[193],"as":[194],"thiazolidinedione":[195],"classes,":[196],"incretin-based":[197],"sodium-glucose":[200],"cotransporter-2":[201],"(SGLT2)":[202],"are":[203,220,246],"middle":[206],"range,":[207],"there":[208],"being":[209],"emerging":[210],"but":[213],"inconsistent":[214],"clinical":[215],"results.":[216],"Nevertheless,":[217],"important":[218],"gaps":[219],"present":[221],"heterogeneity":[223],"study":[226],"design,":[227],"confounded":[228],"severity":[231],"disease,":[234],"insufficient":[236],"cancer-specific":[237],"endpoints":[238],"randomized":[241],"controlled":[242],"trials.":[243],"These":[244],"insights":[245],"reasons":[248],"need":[251],"powered":[254],"studies":[255],"precision":[257],"medicines.":[258],"Conclusions:":[259],"inclusion":[261],"assessment":[265],"diabetes":[267],"care":[268],"enhance":[270],"efficacy":[271],"decision-making":[273],"therapeutic":[275],"settings":[276],"especially":[277],"high-risk":[278],"groups":[279],"rational":[281],"identification":[282],"repurposing":[284],"oncological":[289],"utility.":[290]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7217098259","counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-10-03T00:00:00"}
